# Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy

Study · id `cardio:ct-nct07795593` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07795593](<https://clinicaltrials.gov/study/NCT07795593>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07795593

Browse, organ or system: Kidneys; Metabolism  
Browse, condition area: Diabetes and metabolic disease; Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 600 participants.

## Technical summary

Registry record NCT07795593. Randomized; no masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2031-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 600 participants (planned count; ClinicalTrials.gov record NCT07795593, source copy `cardio:ctgov-nct07795593-2026-10-21`, retrieved 2026-10-26)
- Planned start: 2026-11 (anticipated) (ClinicalTrials.gov record NCT07795593, source copy `cardio:ctgov-nct07795593-2026-10-21`, retrieved 2026-10-26)
- Primary completion: 2031-05 (anticipated) (ClinicalTrials.gov record NCT07795593, source copy `cardio:ctgov-nct07795593-2026-10-21`, retrieved 2026-10-26)
- Completion: 2031-07 (anticipated) (ClinicalTrials.gov record NCT07795593, source copy `cardio:ctgov-nct07795593-2026-10-21`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07795593, source copy `cardio:ctgov-nct07795593-2026-10-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07795593-2026-10-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy
- Acronym: MCPAIN
- Condition: Painful Diabetic Neuropathy (PDN)
- Condition: Diabetic Nephropathies
- Intervention (Device): Cognitive Behavioral Therapy (CBT)
- Intervention (Drug): Oral Medication
- Intervention (Drug): Topical Medication
- Lead sponsor: University of Michigan
- Lead sponsor class: OTHER
- Collaborator: Patient-Centered Outcomes Research Institute
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Diabetic kidney disease (`cardio:diabetic-nephropathy`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: University of Michigan (`cardio:org-university-of-michigan`)
- Registry lists this organization as a collaborator: Patient-Centered Outcomes Research Institute (`cardio:org-patient-centered-outcomes-research-institute`)

## Provenance

Content hash: c5816f7298f099d65f81b0178a0dc25a06a0f962196c06470a195c1c3208bf65
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
